Sign in
EIKN Stock Price, Chart, Stats & News
Eikon Therapeutics, Inc. Common Stock
Save
Eikon Therapeutics, Inc. Common Stock (EIKN) does not currently pay a dividend.
439.06M
Market cap
–
Current P/E
–
Forward P/E
EIKN chart
About
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells.
Similar securities
Based on sector and market capitalization
Report issue